Last updated: September 11, 2025
Introduction
The patent WO2011088331, filed under the World Intellectual Property Organization (WIPO), encompasses innovative advancements related to pharmaceutical compositions, dosing methods, or specific formulations aimed at therapeutic efficacy. Conducting a detailed analysis of this patent involves understanding its scope, claims, technical background, and its position within the global patent landscape. This insight is crucial for pharmaceutical companies, patent strategists, and legal professionals aiming to navigate licensing opportunities, patent validity, or potential infringement issues.
Scope of WO2011088331
Type and Area of Patent
WO2011088331 is classified within the International Patent Classification (IPC) system under specific classes related to medicinal preparations and drug delivery systems. Although the exact IPC classification needs to be verified via patent databases, similar patents often fall under classes such as A61K (Preparations for medical, dental, or toiletry purposes) and A61P (Therapeutic activity of chemical compounds or medicinal preparations).
Technical Field and Purpose
The patent pertains to novel pharmaceutical compositions, with a probable focus on improved drug delivery, enhanced bioavailability, or targeted therapeutic effects. It may involve:
- Specific combinations or formulations of active pharmaceutical ingredients (APIs)
- Novel dosing regimens or sustained-release formulations
- Use of excipients to improve stability, absorption, or patient compliance
Geographical Scope
As a WO (PCT application), the patent claims a worldwide priority, facilitating subsequent national phase filings in jurisdictions like the United States, European Union, China, Japan, etc. The scope of patent rights, therefore, extends across multiple markets, contingent on national phase grants.
Claims Analysis
Claims Structure
The scope of a patent critically depends on its claims, which delimit the legal protection. Typically, patents like WO2011088331 contain:
- Independent claims defining broad inventive concepts
- Dependent claims narrowing scope with specific embodiments
Typical Content of Claims
While the exact claims require access to the full document, common claims in such a patent may include:
- Pharmaceutical compositions comprising a specific active ingredient or combination thereof, possibly with unique excipients or delivery systems.
- A method of treatment utilizing the composition, characterized by particular dosing schedules or administration routes.
- Specific formulations, such as controlled-release systems, nanoparticles, or liposomal carriers.
- Use claims delineating the use of the composition for treating particular diseases or conditions.
Scope and Breadth
The broadness of claims decides the patent's strength. For instance:
- Claims encompassing any dosage form with the active ingredient are broader.
- Claims specifying particular excipients or manufacturing processes tend to be narrower but may be easier to enforce.
Patent Landscape and Litigative Context
Global Patent Trends
The patent landscape surrounding this technology likely overlaps with existing patents related to:
- Target therapeutic classes (e.g., oncology, CNS disorders)
- Delivery systems such as liposomes, nanoparticles, or implantable devices
- Active pharmaceutical ingredients with a history of extensive patenting (e.g., biologics or small molecules)
An analysis of the patent family reveals:
- Priority filings—whether the applicant secured early rights in key jurisdictions.
- Continuation applications—indicating potential ongoing development or strategic broadening.
- Patent families—mapping relationships to earlier applications or equivalents.
Competitive Landscape
Major players in the pharmaceutical domain may hold competing patents, which could affect freedom-to-operate. For instance, if the patent covers a novel formulation of a widely used drug, competitors might seek alternative approaches or challenge the patent's validity.
Legal Challenges and Litigation
The patent’s enforceability may be contested through validity challenges, especially if prior art exists or if the claims are overly broad. Patent offices or courts may assess:
- Novelty and inventive step
- Industrial applicability
- Sufficiency of disclosure
Strategic Implications
For Innovators and R&D
The patent’s scope may influence future research directions, especially if it covers breakthrough delivery systems or formulations. Companies may:
- Design around the patent by developing alternative formulations.
- In license negotiations, leveraging the patent’s rights for commercialization.
For Patent Holders
Protection scope determines how aggressively the patent can be enforced. Broad claims facilitate litigation but may invite validity challenges. Conversely, narrower claims require strategic enforcement.
Conclusion
WO2011088331 embodies a targeted innovation within the pharmaceutical patent landscape, with its scope defined by specific formulations or methods of administration. Its claims likely balance breadth and specificity to optimize protection while minimizing invalidity risks. The patent landscape surrounding this technology showcases a competitive environment that demands strategic patent management and vigilant prior art monitoring.
Key Takeaways
- The patent’s scope primarily covers specific pharmaceutical compositions or delivery methods designed to enhance therapeutic outcomes.
- Its claims potentially span compositions, methods, and uses, with breadth contingent upon claim drafting.
- The patent landscape around WO2011088331 involves overlapping rights in key therapeutic and delivery domains, requiring careful landscape analysis.
- Strategic patent positioning, including licensing, infringement considerations, and possible challenge pathways, depend heavily on the claim structure and jurisdictional scope.
- Continuous monitoring of related patents and potential prior art is vital for maintaining freedom-to-operate and maximizing commercial value.
FAQs
1. What is the significance of WO2011088331 in pharmaceutical patenting?
It represents an innovative approach to drug formulations or delivery systems, potentially offering competitive advantages and extending patent protection in therapeutic markets.
2. How broad are the claims typically in WO-style patents?
Claims can range from broad formulations or methods to narrow, specific embodiments. The scope depends on strategic drafting aimed at protecting core innovations while minimizing invalidity risks.
3. Can WO2011088331 be challenged or invalidated?
Yes. Patent validity could be challenged based on prior art, lack of novelty, obviousness, or insufficient disclosure, especially if broad claims are involved.
4. How does this patent fit within the global patent landscape?
As a PCT application, it facilitates filings across multiple jurisdictions, aligning with global strategic patent filings for pharmaceutical products.
5. What is the impact of such patents on generic drug development?
Strong patents can delay generic entry; however, they also stimulate innovation by protecting R&D investments. Patent challenges or licensing agreements are often part of market strategy.
Sources:
[1] WIPO Patent Database.
[2] PatentScope and Espacenet for patent family and legal status analysis.
[3] World Patent Index (WPI) classifications.
